New treatment strategy may thwart deadly brain tumors

Immune checkpoint inhibitors are important medications that boost the immune system’s response against certain cancers; however, they tend to be ineffective against glioblastoma, the most deadly primary brain tumor in adults. New research in mice led by investigators at Massachusetts General Hospital (MGH) and the University of Florida reveals a promising strategy that makes glioblastoma susceptible to these medications. The […]

Continue reading »

Obesity is a risk factor for cardiotoxicity in chemotherapy-treated patients with breast cancer

Anthracyclines remain a cornerstone of breast cancer therapy in combination with new-generation targeted drugs such as trastuzumab. Both types of drugs are major culprits in chemotherapy-induced heart disease. A recent study showed that being overweight or obese was a risk factor for cardiotoxicity in chemotherapy-treated patients with breast cancer, but it did not take into account related cardiac risk factors […]

Continue reading »

Researchers turn to Yelp reviews to learn how patients with addiction rate their treatment

As the opioid crisis has worsened, addiction treatment programs have proliferated—but there’s no standardized way to rate those programs, researchers at the University of Pennsylvania note in a new study. So they turned to Yelp. The popular online review site is best-known for its restaurant ratings. But it’s also become a clearinghouse for people to rate just about anything—including addiction […]

Continue reading »

Researchers identify neurons responsible for rapid eye movements/REM during sleep

Rapid Eye Movement—not only the name of a successful American rock band, but also and not least a characteristic eye movement in paradoxical sleep, the stage with high dream activity. This sleep phase has a peculiarity: Although the muscle tone of the sleeping person is completely relaxed, the eyes suddenly move back and forth. The name “paradoxical sleep” is well […]

Continue reading »

CRISPR-Cas9 datasets analysis leads to largest genetic screen resource for cancer research

A comprehensive map of genes necessary for cancer survival is one step closer, following the validation of the two largest CRISPR-Cas9 genetic screens in 725 cancer models, across 25 different cancer types. Scientists at the Wellcome Sanger Institute and the Broad Institute of MIT and Harvard compared the consistency of the two datasets, independently verifying the methodology and findings. The […]

Continue reading »

Artificial intelligence can now predict long-term risks of heart attack and cardiac death

A new study in Cardiovascular Research finds that machine learning, the patterns and inferences computers use to learn to perform tasks, can predict the long-term risk of heart attack and cardiac death. Indeed, machine learning appears to be better at predicting heart attacks and cardiac deaths than the standard clinical risk assessment used by cardiologists. Researchers here studied subjects from […]

Continue reading »

Type 1 diabetes: A new starting point to delay autoimmune response

Regulatory T cells (Tregs) prevent excessive immune reactions in healthy people. In the development of autoimmune type 1 diabetes, this protection is not sufficiently effective. Researchers at Helmholtz Zentrum München and LMU Munich have now deciphered a mechanism that impairs Treg differentiation and stability. In the study, when researchers inhibited the molecule that triggers this mechanism, an increased number of […]

Continue reading »
1 32 33 34 35 36 202